Literature DB >> 2041569

Cloning and expression of a complementary DNA encoding a bovine adrenal angiotensin II type-1 receptor.

K Sasaki1, Y Yamano, S Bardhan, N Iwai, J J Murray, M Hasegawa, Y Matsuda, T Inagami.   

Abstract

Angiotensin II elicits different responses which affect cardiovascular, neuronal and electrolyte transport regulation. To understand the mechanisms responsible for its various actions, the receptor for angiotensin II has long been sought, but numerous attempts to purify the receptor have been unsuccessful owing to its instability and low concentration. We report here the expression cloning of a complementary DNA encoding a bovine angiotensin II receptor to overcome these difficulties. The receptor cDNA encodes a protein of 359 amino-acid residues with a transmembrane topology similar to that of other G protein-coupled receptors. COS-7 cells transfected with the cDNA expressed specific and high-affinity binding sites for angiotensin II, angiotensin II antagonist and a non-peptide specific antagonist for type-1 receptor. Dithiothreitol inhibited ligand binding. The concentration of intracellular Ca2+ and of inositol-1,4,5-trisphosphate increased in the transfected COS-7 cells in response to angiotensin II or angiotensin III, indicating that this receptor is the type-1 receptor for angiotensin II. Northern blot analysis revealed that the messenger RNA for this receptor is expressed in bovine adrenal medulla, cortex and kidney.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2041569     DOI: 10.1038/351230a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  81 in total

1.  Multiple templates-based homology modeling enhances structure quality of AT1 receptor: validation by molecular dynamics and antagonist docking.

Authors:  Pandian Sokkar; Shylajanaciyar Mohandass; Murugesan Ramachandran
Journal:  J Mol Model       Date:  2010-10-06       Impact factor: 1.810

2.  Electroporation and electrophoretic DNA transfer into cells. The effect of DNA interaction with electropores.

Authors:  S I Sukharev; V A Klenchin; S M Serov; L V Chernomordik
Journal:  Biophys J       Date:  1992-11       Impact factor: 4.033

3.  Pharmacological characterization of angiotensin II AT(2) receptor subtype heterogeneity in the rat adrenal cortex and medulla.

Authors:  X Lu; K L Grove; W Zhang; R C Speth
Journal:  Endocrine       Date:  1995-04       Impact factor: 3.633

Review 4.  International Union of Basic and Clinical Pharmacology. XCIX. Angiotensin Receptors: Interpreters of Pathophysiological Angiotensinergic Stimuli [corrected].

Authors:  Sadashiva S Karnik; Hamiyet Unal; Jacqueline R Kemp; Kalyan C Tirupula; Satoru Eguchi; Patrick M L Vanderheyden; Walter G Thomas
Journal:  Pharmacol Rev       Date:  2015-10       Impact factor: 25.468

5.  Involvement of the Gi/o/cGMP/PKG pathway in the AT2-mediated inhibition of outer cortex proximal tubule Na+-ATPase by Ang-(1-7).

Authors:  Lucienne da Silva Lara; Fabíola Cavalcante; Flavia Axelband; Aloa Machado De Souza; Anibal Gil Lopes; Celso Caruso-Neves
Journal:  Biochem J       Date:  2006-04-01       Impact factor: 3.857

6.  Distinct roles for the kidney and systemic tissues in blood pressure regulation by the renin-angiotensin system.

Authors:  Steven D Crowley; Susan B Gurley; Michael I Oliverio; A Kathy Pazmino; Robert Griffiths; Patrick J Flannery; Robert F Spurney; Hyung-Suk Kim; Oliver Smithies; Thu H Le; Thomas M Coffman
Journal:  J Clin Invest       Date:  2005-04       Impact factor: 14.808

Review 7.  [The renin-angiotensin system in cardiovascular diseases].

Authors:  C Unterberg; H Kreuzer; A B Buchwald
Journal:  Med Klin (Munich)       Date:  1998-07-15

Review 8.  In hypertension, the kidney breaks your heart.

Authors:  Steven D Crowley; Thomas M Coffman
Journal:  Curr Cardiol Rep       Date:  2008-11       Impact factor: 2.931

9.  Comparative pharmacology of recombinant rat AT1A, AT1B and human AT1 receptors expressed by transfected COS-M6 cells.

Authors:  A J Balmforth; S E Bryson; A J Aylett; P Warburton; S G Ball; K T Pun; D Middlemiss; G M Drew
Journal:  Br J Pharmacol       Date:  1994-05       Impact factor: 8.739

Review 10.  Brain angiotensin II: new developments, unanswered questions and therapeutic opportunities.

Authors:  Juan M Saavedra
Journal:  Cell Mol Neurobiol       Date:  2005-06       Impact factor: 5.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.